Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

394 results about "Scrophularia" patented technology

The genus Scrophularia of the family Scrophulariaceae comprises about 200 species of herbaceous flowering plants commonly known as figworts. Species of Scrophularia all share square stems, opposite leaves and open two-lipped flowers forming clusters at the end of their stems. The genus is found throughout the Northern Hemisphere, but concentrated in Asia with only a few species in Europe and North America.

Chinese medicament for treating pharyngitis

The invention discloses a Chinese medicament for treating pharyngitis, which is a preparation processed by using the following Chinese medicaments in part by weight: 14 to 16 parts of dwarf lilyturf tuber, 14 to 16 parts of coastal glehnia root, 10 to 14 parts of skullcap root, 8 to 12 parts of golden thread, 14 to 16 parts of honeysuckle, 14 to 16 parts of indigowoad leaf, 14 to 16 parts of weeping forsythia, 14 to 16 parts of reed root, 8 to 12 parts of mint, 8 to 12 parts of platycodon root, 8 to 12 parts of blackberrykiky rhizome, 8 to 12 parts of raw rhubarb, 14 to 16 parts of dandelion, 14 to 16 parts of scrophularia root, 8 to 12 parts of burdock seed, 8 to 12 parts of liquorice root and 8 to 12 parts of Vietnamese sophora root. The seventeenth gouts of Chinese medicinal materials are chopped or crushed and then decocted or refluxed and extracted twice by adding water, the decoction is combined, the concentrated medicinal liquid is used for processing aerosol or oral liquid and the like, and the medicinal liquid is further concentrated to obtain extract for processing lozenge or granules and the like. The Chinese medicament has remarkable curative effect of treating sore throat, swelling, inflammation with lymphangoncus and the like, and has quick response; and the total effective rate is more than or equal to 95 percent.
Owner:张沁

Medicament for treating prostatic disease

The invention relates to a medicament for treating a prostatic disease, which is prepared from the following Chinese medical herbs in parts by weight: 40-60 parts of rehmanniae praeparatum, 40-60 parts of rehmanniae vaporata, 50-70 parts of common macrocarpium fruit, 40-60 parts of epimedium, 40-60 parts of morindae, 40-60 parts of desertliving cistanche, 40-60 parts of south dodder seed, 40-60 parts of malaytea scurfpea fruit, 40-60 parts of common cnidium fruit, 40-60 parts of palmleaf raspberry fruit, 30-50 parts of Chinese magnoliavine fruit, 20-40 parts of cassia bark, 30-50 parts of fennel fruit, 30-50 parts of cervus nippon temminck, 30-50 parts of eucommia bark, 30-50 parts of achyranthes root, 30-50 parts of Indian buead, 30-50 parts of dioscoreae, 30-50 parts of Chinese eaglewood, 40-60 parts of dendrobium, 40-60 parts of scrophularia, 30-50 parts of cluster mallow fruit, 40-60 parts of herba pyrrosiae, 40-60 parts of plantago seed, 40-60 parts of rhizoma anemarrhenae, 40-60 parts of phellodendron, 40-60 parts of white paeony root and 30-50 parts of raw liquorice root, and capsules are prepared by the steps of grinding the Chinese medical herbs into fine powder and encapsuling. The medicament has effects of invigorating yin, supporting yang, resuscitating and treating stranguria and is mainly suitable for chronic prostatitis or prostatic hyperplasia.
Owner:徐海彬

Chinese medicinal composition for treating leukemia

The invention discloses a Chinese medicinal composition for treating leukemia. The Chinese medicinal composition is prepared from Chinese herbal medicines in part by weight: 60 to 150 parts of glossy privet fruit, 20 to 80 parts of Chinese magnoliavine fruit, 60 to 150 parts of reed rhizome, 20 to 80 parts of common selfheal fruit, 20 to 80 parts of cinnamomvine, 20 to 80 parts of malaytea scurfpea fruit, 60 to150 parts of desertliving cistanche, 20 to 80 parts of eucommia bark, 20 to 80 parts of eclipta alba, 20 to 80 parts of mulberry, 20 to 80 parts of white paeony root, 20 to 80 parts of red paeony root, 60 to 150 parts of anemarrhena asphodeloides, 20 to 80 parts of sweet wormwood herb, 20 to 80 parts of dried rehmannia root, 20 to 80 parts of prepared rehmannia root, 20 to 80 parts of fragrant solomonseal rhizome, 100 to 200 parts of Chinese angelica, 20 to 80 parts of astragalus, 5 to 35 parts of licorice root, 20 to 80 parts of honeysuckle flower, 20 to 80 parts of peach seed, 20 to 80 parts of Indian buead, 20 to 80 parts of largehead atractylodes rhizome, 20 to 80 parts of red date, 20 to 80 parts of medlar, 20 to 80 parts of small red beans, 20 to 80 parts of swordlike atractylodes rhizome, 100 to 200 parts of gloss ganoderma, 20 to 80 parts of scrophularia, 20 to 80 parts of rhubarb, 9 to 20 parts of Chinese caterpillar fungus, 50 to 120 parts of ginseng, 60 to 150 parts of American ginseng, 9 to 20 parts of saffron, 20 to 80 parts of bletilla striata, 20 to 80 parts of rhodiola rosea, 20 to 80 parts of notoginseng root, 20 to 80 parts of turtle shell, 20 to 80 parts of India mockstrawberry herb and 300 to 700 parts of deer medulla spinalis.
Owner:姜爱军

Medicament for treating myoma of uterus and preparation method thereof

The invention discloses a medicament for treating myoma of uterus, which is characterized by being prepared from the following raw materials in part by weight: 1 to 20 parts of rose, 1 to 20 parts of seville orange flower, 1 to 20 parts of Chinese angelica, 1 to 20 parts of red paeony root, 1 to 20 parts of szechuan lovage rhizome, 1 to 20 parts of red tangerine peel, 1 to 20 parts of rhizome pinelliae preparata, 1 to 20 parts of honey-fried liquorice root, 1 to 20 parts of pared nutgrass galingale rhizome, 1 to 20 parts of scrophularia root, 1 to 20 parts of thunberg fritillary bulb, 1 to 20 parts of dipsacus asper, 1 to 20 parts of fructus aurantii immaturus, 1 to 20 parts of sudden smile powder, 1 to 20 parts of raw hawthorn fruit, 1 to 20 parts of oyster shell, 1 to 20 parts of spreading hedyotis herb, 1 to 20 parts of zedoary and 1 to 20 parts of over 95 percent edible ethanol. The medicament can be used for oral administration and absorbed by the spleen and stomach and can be used for external use and absorbed by skin, and can be absorbed complexly in two modes of oral administration and external use. The medicament has the advantages of addressing both the symptoms and root causes along with reasonable formula, simple compatibility and definite curative effect, and is particularly suitable for infecund patients caused by blood stasis and qi depression and phlegm-damp stagnation. The invention also provides a preparation method of the medicament.
Owner:葛德钜 +1
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products